AVA vs MGEE

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score limits distress risk assessment. AVA trades near its analyst target price of $41.00 and slightly below the growth-based intrinsic value of $69.62, but well above the conservative Graham Number of $41.55. Strong recent earnings growth (YoY +56.4%) and a high dividend yield (4.83%) are offset by declining earnings estimate accuracy, insider selling, and weak technical momentum. Relative to sector peers, AVA has below-average revenue growth and profitability but a more stable payout and moderate leverage.

MGEE presents a dichotomy between superior operational efficiency and poor valuation metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts profit margins and ROE significantly above sector averages, the stock is trading at a substantial premium to its Graham Number ($54.65) and Intrinsic Value ($54.50). The technical trend is currently bearish (0/100), and a consistent history of missing earnings estimates suggests limited near-term catalysts for price appreciation despite a conservative debt profile.